COMP <GO>
LIFE vs BAC // ENTERPRISE SCALE & MARKET CAP
Ethos Technologies Inc. (Class A) (NASDAQ) VS. Bank of America Corporation (NYSE) • 15-METRIC TALLY: LIFE 3
— BAC 7
▲ ENTERPRISE SCALE & MARKET CAP LEADER: BAC
LAST: $43.62 (+1.85%) • MKT CAP: $2.83B
market-cap
$2.83B
LAST: $51.14 (+0.57%) • MKT CAP: $357.61B
market-cap
$357.61B
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (LIFE VS. BAC)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | LIFE | BAC | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 40.60% | 2.50% | +38.10 | LIFE | /roic <GO> |
| EV/EBITDA & P/E Valuation | 37.0x | 30.2x | +6.80 | BAC | /valuation <GO> |
| Free Cash Flow Yield | 1.23% | 2.10% | -0.87 | BAC | /fcf-yield <GO> |
| Operating Margin | 18.80% | 32.90% | -14.10 | BAC | /operating-margins <GO> |
| Net Profit Margin | 18.40% | 27.00% | -8.60 | BAC | /net-margins <GO> |
| Revenue Growth (YoY) | 52.00% | 6.80% | +45.20 | LIFE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 7/9 | -1.00 | BAC | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 65.1 | 38.3 | +26.84 | LIFE | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.90 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 33.4x | 10.9x | +22.50 | BAC | /forward-pe <GO> |
| Enterprise Scale & Market Cap ACTIVE | $2.83B | $357.61B | -$354.77B | BAC | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | LIFE REV | BAC REV | LIFE GROSS % | BAC GROSS % | LIFE FCF | BAC FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $387.6M | $113.10B | — | — | $34.7M | $7.52B |
| FY 2024 | $254.9M | $105.86B | — | — | -$11.7M | -$13.57B |
| FY 2023 | — | $102.77B | — | — | — | $40.36B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
LIFE // BETA —
BAC // BETA 0.90